Cargando…
Biapenem, a Carbapenem Antibiotic, Elicits Mycobacteria Specific Immune Responses and Reduces the Recurrence of Tuberculosis
Tuberculosis (TB) still tops the list of global health burdens even after COVID-19. However, it will sooner transcend the current pandemic due to the prevailing risk of reactivation of latent TB in immunocompromised individuals. The indiscriminate misuse and overuse of antibiotics have resulted in t...
Autores principales: | Pahuja, Isha, Verma, Akanksha, Ghoshal, Antara, Mukhopadhyay, Suparba, Kumari, Anjna, Shaji, Aishwarya, Chaturvedi, Shivam, Dwivedi, Ved Prakash, Bhaskar, Ashima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434282/ https://www.ncbi.nlm.nih.gov/pubmed/37272833 http://dx.doi.org/10.1128/spectrum.00858-23 |
Ejemplares similares
-
Withaferin A Protects against Primary and Recurrent Tuberculosis by Modulating Mycobacterium-Specific Host Immune Responses
por: Kumari, Anjna, et al.
Publicado: (2023) -
Berberine governs NOTCH3/AKT signaling to enrich lung-resident memory T cells during tuberculosis
por: Pahuja, Isha, et al.
Publicado: (2023) -
SIRT2 inhibition by AGK2 enhances mycobacteria-specific stem cell memory responses by modulating beta-catenin and glycolysis
por: Bhaskar, Ashima, et al.
Publicado: (2023) -
Tuberculosis: The success tale of less explored dormant Mycobacterium tuberculosis
por: Verma, Akanksha, et al.
Publicado: (2022) -
The 1, 2-ethylenediamine SQ109 protects against tuberculosis by promoting M1 macrophage polarization through the p38 MAPK pathway
por: Singh, Mona, et al.
Publicado: (2022)